BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Miller S, Daily L, Leishman E, Bradshaw H, Straiker A. Δ9-Tetrahydrocannabinol and Cannabidiol Differentially Regulate Intraocular Pressure. Invest Ophthalmol Vis Sci 2018;59:5904-11. [PMID: 30550613 DOI: 10.1167/iovs.18-24838] [Cited by in Crossref: 23] [Cited by in F6Publishing: 18] [Article Influence: 7.7] [Reference Citation Analysis]
Number Citing Articles
1 Straiker A. What is currently known about cannabidiol and ocular pressure. Expert Review of Ophthalmology 2019;14:259-61. [DOI: 10.1080/17469899.2019.1698947] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
2 Williams MR, Holbrook TC, Maxwell L, Croft CH, Ientile MM, Cliburn K. Pharmacokinetic Evaluation of a Cannabidiol Supplement in Horses. J Equine Vet Sci 2021;110:103842. [PMID: 34923070 DOI: 10.1016/j.jevs.2021.103842] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
3 Casson RJ. Medical therapy for glaucoma: A review. Clin Exp Ophthalmol 2022;50:198-212. [PMID: 35037367 DOI: 10.1111/ceo.13989] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
4 Chan JZ, Duncan RE. Regulatory Effects of Cannabidiol on Mitochondrial Functions: A Review. Cells 2021;10:1251. [PMID: 34069407 DOI: 10.3390/cells10051251] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
5 Biringer RG. Endocannabinoid signaling pathways: beyond CB1R and CB2R. J Cell Commun Signal 2021;15:335-60. [PMID: 33978927 DOI: 10.1007/s12079-021-00622-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Chetoni P, Burgalassi S, Zucchetti E, Granchi C, Minutolo F, Tampucci S, Monti D. MAGL inhibitor NanoMicellar formulation (MAGL-NanoMicellar) for the development of an antiglaucoma eye drop. Int J Pharm 2022;:122078. [PMID: 35932931 DOI: 10.1016/j.ijpharm.2022.122078] [Reference Citation Analysis]
7 Miller S, Daily L, Dharla V, Gertsch J, Malamas MS, Ojima I, Kaczocha M, Ogasawara D, Straiker A. Endocannabinoid metabolism and transport as targets to regulate intraocular pressure. Exp Eye Res 2020;201:108266. [PMID: 32979397 DOI: 10.1016/j.exer.2020.108266] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
8 Murataeva N, Daily L, Taylor X, Dhopeshwarkar A, Hu SS, Miller S, McHugh D, Oehler O, Li S, Bonanno JA, Mackie K, Straiker A. Evidence for a GPR18 Role in Chemotaxis, Proliferation, and the Course of Wound Closure in the Cornea. Cornea 2019;38:905-13. [PMID: 30969262 DOI: 10.1097/ICO.0000000000001934] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
9 Ibarra-Lecue I, Diez-Alarcia R, Urigüen L. Serotonin 2A receptors and cannabinoids. Prog Brain Res 2021;259:135-75. [PMID: 33541675 DOI: 10.1016/bs.pbr.2021.01.004] [Reference Citation Analysis]
10 Rock EM, Sullivan MT, Collins SA, Goodman H, Limebeer CL, Mechoulam R, Parker LA. Evaluation of repeated or acute treatment with cannabidiol (CBD), cannabidiolic acid (CBDA) or CBDA methyl ester (HU-580) on nausea and/or vomiting in rats and shrews. Psychopharmacology (Berl) 2020;237:2621-31. [PMID: 32488349 DOI: 10.1007/s00213-020-05559-z] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 3.5] [Reference Citation Analysis]
11 Wang MTM, Danesh-Meyer HV. Cannabinoids and the eye. Surv Ophthalmol 2021;66:327-45. [PMID: 32763339 DOI: 10.1016/j.survophthal.2020.07.002] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
12 Vallée A, Lecarpentier Y, Vallée JN. Cannabidiol and the Canonical WNT/β-Catenin Pathway in Glaucoma. Int J Mol Sci 2021;22:3798. [PMID: 33917605 DOI: 10.3390/ijms22073798] [Reference Citation Analysis]
13 Gonçalves J, Rosado T, Soares S, Simão AY, Caramelo D, Luís Â, Fernández N, Barroso M, Gallardo E, Duarte AP. Cannabis and Its Secondary Metabolites: Their Use as Therapeutic Drugs, Toxicological Aspects, and Analytical Determination. Medicines (Basel) 2019;6:E31. [PMID: 30813390 DOI: 10.3390/medicines6010031] [Cited by in Crossref: 33] [Cited by in F6Publishing: 34] [Article Influence: 11.0] [Reference Citation Analysis]
14 Pujari R, Jampel HD. Treating Glaucoma with Medical Marijuana: Peering through the Smoke. Ophthalmol Glaucoma 2019;2:201-3. [PMID: 32672538 DOI: 10.1016/j.ogla.2019.02.007] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
15 Miller S, Daily L, Ploss M, Greig I, Ross R, Rayana NP, Dai J, Sugali CK, Mao W, Straiker A. Evidence that cannabinoid CB1 receptors regulate intraocular pressure via two opposing mechanisms. Exp Eye Res 2020;200:108241. [PMID: 32941875 DOI: 10.1016/j.exer.2020.108241] [Reference Citation Analysis]
16 Jia JS, Mehran N, Purgert R, Zhang QE, Lee D, Myers JS, Kolomeyer NN. Marijuana and Glaucoma: A Social Media Content Analysis. Ophthalmol Glaucoma 2021;4:400-4. [PMID: 33242684 DOI: 10.1016/j.ogla.2020.11.004] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
17 Morales P, Lago-Fernandez A, Hurst DP, Sotudeh N, Brailoiu E, Reggio PH, Abood ME, Jagerovic N. Therapeutic Exploitation of GPR18: Beyond the Cannabinoids? J Med Chem 2020;63:14216-27. [PMID: 32914978 DOI: 10.1021/acs.jmedchem.0c00926] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
18 Sweeney C, Dudhipala N, Thakkar R, Mehraj T, Marathe S, Gul W, ElSohly MA, Murphy B, Majumdar S. Effect of surfactant concentration and sterilization process on intraocular pressure-lowering activity of Δ9-tetrahydrocannabinol-valine-hemisuccinate (NB1111) nanoemulsions. Drug Deliv Transl Res 2021;11:2096-107. [PMID: 33169348 DOI: 10.1007/s13346-020-00871-9] [Cited by in Crossref: 6] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
19 Abyadeh M, Gupta V, Paulo JA, Gupta V, Chitranshi N, Godinez A, Saks D, Hasan M, Amirkhani A, McKay M, Salekdeh GH, Haynes PA, Graham SL, Mirzaei M. A Proteomic View of Cellular and Molecular Effects of Cannabis. Biomolecules 2021;11:1411. [PMID: 34680044 DOI: 10.3390/biom11101411] [Reference Citation Analysis]
20 Rebibo L, Frušić-Zlotkin M, Ofri R, Nassar T, Benita S. The dose-dependent effect of a stabilized cannabidiol nanoemulsion on ocular surface inflammation and intraocular pressure. Int J Pharm 2022;:121627. [PMID: 35245638 DOI: 10.1016/j.ijpharm.2022.121627] [Reference Citation Analysis]
21 Weldy EW, Stanley J, Koduri VA, McCourt EA, Patnaik JL, Kahook MY, Seibold LK. Perceptions of Marijuana Use for Glaucoma from Patients, Cannabis Retailers, and Glaucoma Specialists. Ophthalmol Glaucoma 2020;3:453-9. [PMID: 32782211 DOI: 10.1016/j.ogla.2020.06.009] [Reference Citation Analysis]
22 Mosaed S, Smith AK, Liu JHK, Minckler DS, Fitzgerald RL, Grelotti D, Sones E, Weinreb RN, Marcotte TD. The Relationship Between Plasma Tetrahydrocannabinol Levels and Intraocular Pressure in Healthy Adult Subjects. Front Med 2022;8:736792. [DOI: 10.3389/fmed.2021.736792] [Reference Citation Analysis]
23 Kennedy EKC, Perono GA, Nemez DB, Holloway AC, Thomas PJ, Letcher R, Marvin C, Stetefeld J, Stout J, Peters O, Palace V, Tomy G. Increasing cannabis use and importance as an environmental contaminant mixture and associated risks to exposed biota: A review. Critical Reviews in Environmental Science and Technology 2022;52:203-39. [DOI: 10.1080/10643389.2020.1819730] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
24 Jordan E, Nguyen GN, Piechot A, Kayser O. Cannabinoids as New Drug Candidates for the Treatment of Glaucoma. Planta Med 2022. [PMID: 35299275 DOI: 10.1055/a-1665-3100] [Reference Citation Analysis]
25 Thayer A, Murataeva N, Delcroix V, Wager-Miller J, Makarenkova HP, Straiker A. THC Regulates Tearing via Cannabinoid CB1 Receptors. Invest Ophthalmol Vis Sci 2020;61:48. [PMID: 32852544 DOI: 10.1167/iovs.61.10.48] [Reference Citation Analysis]
26 Lowin T, Tingting R, Zurmahr J, Classen T, Schneider M, Pongratz G. Cannabidiol (CBD): a killer for inflammatory rheumatoid arthritis synovial fibroblasts. Cell Death Dis 2020;11:714. [PMID: 32873774 DOI: 10.1038/s41419-020-02892-1] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]